Puing AG, Ho S, Frankel P, Tegtmeier B, et al. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience. J Infect Dis 2022;225:352-354.
PMID: 34379763